Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Temozolomide in Treating Patients With Invasive Pituitary Tumors

This study has been withdrawn prior to enrollment.
(funding term ended)
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
Jonsson Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT00601289
First received: January 25, 2008
Last updated: July 27, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)